Sumatra, Kimberly .

HRN: 22-74-67  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/12/2023
AMPICILLIN 1GM (VIAL)
03/12/2023
03/13/2023
IVTT
2g
2g Now Then Q6 Hours
PROM
Waiting Final Action 
03/12/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/12/2023
03/12/2023
IV NOW
500mg IV
500 Mg Now
PROM
Waiting Final Action 
03/12/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/12/2023
03/13/2023
IV
500mg
Q8 Hours For 2 Doses
S/p LSCS
Waiting Final Action 
03/13/2023
CO-AMOXICLAV 625MG (TAB)
03/13/2023
03/20/2023
PO
625 Mg
Every 8 Hours
Thickly Meconium-Stained Amniotic Fluid
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: